Development of Monoclonal Antibodies in China: Overview and Prospects
Joint Authors
Wang, Yi-Tao
Zhang, Mao-Yu
Lu, Jin-Jian
Wang, Liang
Gao, Zi-Chao
Hu, Hao
Ung, Carolina Oi Lam
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-02-25
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
Monoclonal antibodies (mAbs) have become increasingly important as human therapeutic agents.
Yet, current research concentrates on technology itself and pays attention to developed countries.
This paper aims to provide a comprehensive review of mAbs development in China through systematic analysis of drug registry, patent applications, clinical trials, academic publication, and ongoing R&D projects.
The trends in therapeutic areas and industrialization process are also highlighted.
Development and research trends of mAbs are analyzed to provide a future perspective of mAbs as therapeutic agents in China.
American Psychological Association (APA)
Zhang, Mao-Yu& Lu, Jin-Jian& Wang, Liang& Gao, Zi-Chao& Hu, Hao& Ung, Carolina Oi Lam…[et al.]. 2015. Development of Monoclonal Antibodies in China: Overview and Prospects. BioMed Research International،Vol. 2015, no. 2015, pp.1-10.
https://search.emarefa.net/detail/BIM-1054466
Modern Language Association (MLA)
Zhang, Mao-Yu…[et al.]. Development of Monoclonal Antibodies in China: Overview and Prospects. BioMed Research International No. 2015 (2015), pp.1-10.
https://search.emarefa.net/detail/BIM-1054466
American Medical Association (AMA)
Zhang, Mao-Yu& Lu, Jin-Jian& Wang, Liang& Gao, Zi-Chao& Hu, Hao& Ung, Carolina Oi Lam…[et al.]. Development of Monoclonal Antibodies in China: Overview and Prospects. BioMed Research International. 2015. Vol. 2015, no. 2015, pp.1-10.
https://search.emarefa.net/detail/BIM-1054466
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1054466
